Lupus Drug Fails to Reduce Symptoms in Mid-stage Study Lupus Drug Fails to Reduce Symptoms in Mid-stage Study
Roivant Sciences said on Monday its experimental drug to treat systemic lupus erythematosus failed to reduce symptoms of the autoimmune disease in a mid-stage study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
How Viral Infections Cause Long-Term Health Problems
In a few patients, the immune system becomes misdirected, attacking the body instead of the virus. (Source: NYT Health)
Source: NYT Health - November 22, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Multiple Sclerosis Autoimmune Diseases Immune System Long Covid Chronic Fatigue Syndrome Antibodies Mononucleosis Rheumatoid Arthritis Bacteria Lupus Erythematosus Source Type: news
Risks Quantified in Medically Optimized Pregnancy With Lupus Risks Quantified in Medically Optimized Pregnancy With Lupus
Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 22, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Obinutuzumab Preserves Kidney Function in Lupus Nephritis
THURSDAY, Nov. 16, 2023 -- For patients with lupus nephritis (LN), obinutuzumab treatment results in better preservation of kidney function and prevention of LN flares, according to a study published online Nov. 10 in Arthritis&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2023 Category: Pharmaceuticals Source Type: news
Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnancy in Rheumatic Disease Quadruples CVE Risk
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than did pregnant individuals without these conditions.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 13, 2023 Category: Cardiology Tags: Rheumatology News Source Type: news
B-Cell Depletion Helps Maintain Kidney Function in Lupus Nephritis
(MedPage Today) -- SAN DIEGO -- Treatment with the B-cell depleting agent obinutuzumab (Gazyva) helped patients with lupus nephritis avoid the most serious adverse outcomes, according to a post hoc analysis of randomized trial data.
Among 125... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 10, 2023 Category: Rheumatology Source Type: news
Obinutuzumab Promotes Renal Preservation in Lupus Nephritis Obinutuzumab Promotes Renal Preservation in Lupus Nephritis
A post hoc analysis of the NOBILITY trial showed improved outcomes for patients taking obinutuzumab (Gazyva) compared with placebo.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 10, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Antiphospholipid Antibodies Vary by Race in People With SLE Antiphospholipid Antibodies Vary by Race in People With SLE
A study of multiple cohorts of patients with systemic lupus erythematosus showed significantly lower prevalence of antiphospholipid antibodies (aPLs) among Black patients.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 2, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Major Source of Lupus Morbidity More Common in Certain Racial-Ethnic Groups
(MedPage Today) -- Among patients with systemic lupus erythematosus (SLE), high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found.
Rates for most... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 25, 2023 Category: American Health Source Type: news
Nkarta stock soars 112% after FDA clears cell therapy to go beyond cancer into lupus
Nkarta wants cell therapy to go beyond cancer and has been given the FDA green light to move forward with a CAR NK candidate in human trials for lupus—news that sent the company’s stock soaring 112%. “Autoimmune patients have limited options these days, and those options that they have are often…#nkarta #fda #autoimmune #paulhastings #fiercebiotech #nkx019 #davidshook #fierce #sle #shook (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2023 Category: Consumer Health News Source Type: news
Peninsula biotech's stock soars as it cuts staff, focuses cell therapy on autoimmune diseases
The company's stock finished Tuesday 110% higher after it outlined plans to cut staff by 10%, extend its cash runway and focus on diseases like lupus. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 17, 2023 Category: Biotechnology Authors: Ron Leuty Source Type: news
Tapering Lupus Drugs in Stable Patients: Flare Risks Studied Tapering Lupus Drugs in Stable Patients: Flare Risks Studied
Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 3, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Are Cellular Therapies the Future of Autoimmune Disease? Are Cellular Therapies the Future of Autoimmune Disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR-T cell therapy to treat -- and possibly cure -- autoimmune diseases like lupus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Ginger May Ease Inflammation of Autoimmune Diseases
MONDAY, Sept. 25, 2023 -- Ginger supplements may help those with certain autoimmune diseases, such as lupus and rheumatoid arthritis, control inflammation.
New research has added evidence to support the impact of ginger on white blood cell function,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 25, 2023 Category: General Medicine Source Type: news
Lupus May Overlap in Many Patients With Systemic Sclerosis Lupus May Overlap in Many Patients With Systemic Sclerosis
Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) showed a distinct clinical phenotype from those with SSc alone, but mortality was similar.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
